Kalydeco is a prescription treatment used for certain people living with cystic fibrosis. It works by targeting specific genetic mutations linked to the condition and may help improve lung function and overall quality of life. Many patients use this medication as part of a broader treatment plan that includes airway clearance, nutrition support.
Cystic fibrosis is a genetic condition that affects the lungs, digestive system, and other organs. It causes thick and sticky mucus to build up in the body, leading to breathing difficulties and repeated infections. Kalydeco is a medication designed to help certain cystic fibrosis patients by improving the function of a protein linked to the disease. Doctors may prescribe this treatment for patients who have specific gene mutations associated with cystic fibrosis.